Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-004961

Chief Financial Officer gave up 4,555 shares (to pay taxes)

  • Chief Financial Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hirsch Andrew Chief Financial Officer 2019-01-20 Option exercise +15,000 15,000 D
Hirsch Andrew Chief Financial Officer 2019-01-22 Shares withheld for taxes −4,555 $52.82 $240,595 10,445 D
Derivatives
Hirsch Andrew Chief Financial Officer 2019-01-20 Option exercise · Performance share unit −15,000 0 D
Loading xslF345X03/doc4.xml…